European Commission (EC) has granted marketing authorization for Lorviqua as monotherapy for treatment of patients with anaplastic lymphoma kinase (ALK) – positive advanced non-small cell lung cancer. Lorviqua is approved in US…
Tag: Treatment Options For Lung Cancer
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is called as RATS which is…
Chemotherapy and Immunotherapy Combination to Provide Effective Lung Cancer Treatment
According to a study published in Science Translational Medicine, a combination of two cancer treatments could provide effective treatment for lung cancer by targeting immune cells involved with formulation of tumors. The…
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has been developed by Ashish Dutta, Professor at IIT Kanpur, Professor…
Palliative Care and Lung Cancer
The deadly disease of lung cancer occurs when the cells in lung grow uncontrollably and form a mass called as tumor. This lung cancer can begin anywhere in the lung and once…
What is Combination Therapy for Metastatic Lung Cancer?
Most of the times, lung cancer is found when it has already spread to other parts of the body. It may have travel to lymph nodes near or away from lung, the…
FDA Approves First Targeted Therapy for Lung Cancer with Specific Genetic Mutation
The U.S. Food and Drug Administration has approved Lumakras (sotorasib) as first treatment for non-small cell lung cancer patients whose tumors have specific type of genetic mutation called KRAS G12C. It is…